Glyko Biomedical Ltd. other research news

The Novato, Calif., company received two grants to develop diagnostic tests for lysosomal storage diseases.

A Phase I SBIR grant for $67,000, from the NIH’s Division of Child Health and Human Development, will fund research extending the utility of the company’s first generation Urinary Carbohydrate Analysis screening test for 25 lysosomal storage diseases, such as Tay-Sachs and Gaucher disease. ...